Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.
Journal: Lancet (London, England)
Published: April 22, 2026
Evaluating oral selexipag in pulmonary arterial hypertension: Insights on survival, safety, and dosing patterns from the complete observation period of GRIPHON and its open-label extension.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: July 30, 2025
Vigorous But Not Moderate Physical Activity Is Associated With Reduced Cardiovascular Disease Risk In Young Hispanic Men.
Journal: The American journal of cardiology
Published: January 29, 2025
Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
Journal: Circulation
Published: May 16, 2024
Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil.
Journal: Respiratory medicine
Published: April 12, 2023
Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil.
Journal: Pulmonary circulation
Published: February 22, 2023
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repository.
Journal: Pulmonary circulation
Published: November 18, 2022
Using a knowledge translation program to facilitate guideline- and evidence-based patient management: the PAH-QuERI Extension Program.
Journal: Pulmonary circulation
Published: January 21, 2022
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
Journal: American journal of respiratory and critical care medicine
Published: December 14, 2021
Author rebuttal to response regarding "Letter to the Editor regarding 'Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?'".
Journal: Pulmonary circulation
Published: July 09, 2020
Last Updated: 09/26/2026